STRATA CRITICAL MEDICAL, INC. (SRTA) Gross Margin
- Gross margin · 12 months: Value 21.25%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 21.25% | Gross profit / revenue. Period ending 2026-06-30. $54.40M ÷ $255.97M × 100 ≈ 21.25% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 54.40M USD | Gross Profit |
| Revenue | 255.97M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $54.40M | $255.97M | (m) | 21.25% |
| 2026-03-31 | $48.19M | $228.58M | (m) | 21.08% |
| 2025-12-31 | $41.13M | $197.14M | (m) | 20.86% |
| 2025-09-30 | (m) | $268.62M | (m) | (m) |
| 2025-06-30 | (m) | $254.34M | (m) | (m) |
| 2025-03-31 | (m) | $251.49M | (m) | (m) |
| 2024-12-31 | (m) | $248.69M | (m) | (m) |
| 2024-09-30 | (m) | $241.81M | (m) | (m) |
| 2024-06-30 | (m) | $238.38M | (m) | (m) |
| 2024-03-31 | (m) | $231.42M | (m) | (m) |
| 2023-12-31 | (m) | $225.18M | (m) | (m) |
| 2023-09-30 | (m) | $215.84M | (m) | (m) |
| 2023-06-30 | (m) | $190.12M | (m) | (m) |
| 2023-03-31 | (m) | $164.76M | (m) | (m) |
| 2022-12-31 | (m) | $146.12M | (m) | (m) |
| 2022-09-30 | (m) | $132.60M | (m) | (m) |
| 2022-06-30 | (m) | $107.20M | (m) | (m) |
| 2022-03-31 | (m) | $84.52M | (m) | (m) |
| 2021-12-31 | (m) | $67.16M | (m) | (m) |
| 2021-09-30 | (m) | $50.53M | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $23.43M | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | $31.20M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |